Praxair Prevails In Mallinckrodt's Respiratory Drug Patent Suit
A Delaware federal judge dealt a blow to Mallinckrodt in a patent suit against Praxair on Tuesday, when he ruled that several patents covering the respiratory drug Inomax were invalid for claiming only...To view the full article, register now.
Already a subscriber? Click here to view full article